ER degradation for ER+/HER2– advanced or metastatic breast cancer: a phase 1 trial

E Erika Hamilton R Rachel M. Layman (Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA) D David Cosgrove M Michael Danso H Hui Zhang (The Fourth Hospital of Hebei Medical University Shijiazhuang China) W Wei He S Su Young Kim J Jie Fan (Zhejiang Key Laboratory of Low-Carbon Synthesis of Value-Added Chemicals, State Key Laboratory of Soil Pollution Control and Safety, Department of Chemistry) M Manish R. Patel

Article Details

Volume / Issue Vol. 17, Issue 1
Published December 17, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (9)

E

Erika Hamilton

R

Rachel M. Layman

Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

D

David Cosgrove

M

Michael Danso

H

Hui Zhang

The Fourth Hospital of Hebei Medical University Shijiazhuang China

W

Wei He

S

Su Young Kim

J

Jie Fan

Zhejiang Key Laboratory of Low-Carbon Synthesis of Value-Added Chemicals, State Key Laboratory of Soil Pollution Control and Safety, Department of Chemistry

M

Manish R. Patel